[Prolonged action neuroleptics (review of the foreign literature)].
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001714:Bipolar Disorder / Q000188:drug therapy; D002648:Child; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D003984:Dibenzazepines / Q000627:therapeutic use; D003988:Dibenzothiepins / Q000627:therapeutic use; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010259:Paranoid Disorders / Q000188:drug therapy; D010546:Perphenazine / Q000008:administration & dosage; D010868:Pimozide / Q000008:administration & dosage / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013329:Structure-Activity Relationship; D013881:Thioridazine / Q000008:administration & dosage; D013892:Thioxanthenes / Q000008:administration & dosage / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D003984:Dibenzazepines; D003988:Dibenzothiepins; D004304:Dosage Forms; D010879:Piperazines; D010880:Piperidines; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D010868:Pimozide; D010546:Perphenazine; D013881:Thioridazine; D005476:Fluphenazine
Neĭroleptiki prolongirovannogo deĭstviia (obzor inostrannoĭ literatury)